Barclays downgraded DexCom (DXCM) to Underweight from Equal Weight with a price target of $71, down from $80.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DXCM:
- DexCom reports preliminary Q4 revenue $1.26B, consensus $1.24B
- DexCom sees FY26 revenue $5.16B-$5.25B, consensus $5.23B
- DexCom price target raised to $86 from $84 at Bernstein
- Dexcom: Reset Expectations, Strengthened Fundamentals, and Operating Leverage Support Reiterated Buy Rating
- DexCom call volume above normal and directionally bullish